Clinical comparison of efficacy of Alloplast (Biograft HT) and PRF (Platelet Rich Fibrin) in the treatment of intrabony defects

Anuva Bhardwaj; Monika Ahlawat; Meenakshi Chopra; Akanksha Joon; P. K. Asmin; Meenu Godara

doi:10.53730/ijhs.v6nS6.10094

Authors

Anuva Bhardwaj
bhardwajanuva1@gmail.com
Senior Lecturer, Department of Pedodontics, Rayat Bahra Dental College and Hospital, Mohali, Punjab, India
Monika Ahlawat Senior Lecturer, Department of Conservative Dentistry and Endodontics, Faculty of Dental Sciences, P.D.M University, Bahadurgarh, Haryana, India
Meenakshi Chopra Associate Professor, Department of Public Health Dentistry SGT Dental College, Hospital and Research Institute, Gurugram, Haryana, India
Akanksha Joon Senior Lecturer, Department of Conservative Dentistry and Endodontics, Faculty of Dental Sciences, SGT University, Gurugram, Haryana, India
Asmin P. K. Assistant Professor, Department of Public Health Dentistry, Coorg Institute of Dental Sciences, Virajpet, Karnataka, India
Meenu Godara PG Student, Department of Conservative Dentistry and Endodontics, Faculty of Dental Sciences, P.D.M University, Bahadurgarh, Haryana, India

Keywords:

Bone, Depth, Graft, Pocket

Abstract

Introduction: Clinical and Radiographic comparison of the efficacy of an alloplast (Biograft-HT®*) and Platelet rich fibrin (PRF) in the treatment of intrabony defects. Materials and Methods: A total number of 88 sites in 32 subjects were selected for the study and divided in two groups on basis of material use for treatment i.e platelet rich fibrin (PRF) and biograft-HT®. Results: The statistical analysis was done using SPSS (Statistical Package for Social Sciences) Version 15.0 statistical Analysis Software. At baseline there was no statistically significant difference between the groups. Conclusion: The comparison of PPD and CAL measurements between the two groups at different time intervals revealed no statistically significant difference. The defect fill and the percentage defect fill from 3 to 6 months was statistically significant in two groups.

Downloads

Download data is not yet available.

References

Chandrashekar KT, Saxena C. Biograft-HT® as a bone graft material in the treatment of periodontal vertical defects and its clinical and radiological evaluation. J Indian Soc Periodontol 2009;13:138-144.

Trisi P, Rao W, Rebaudi A, Fiore P. Histologic effects of pure phase beta tricalcium phosphate on bone regeneration in human artificial jaw bone defects. Int J Periodontics Restorative Dent 2003;23:69-77.

Mefferet RM, Thomas JR, Hemilton KM, Brownstein CM. Hydroxyapatite as an alloplastic graft in the treatment of human periodontal osseous defects. J Periodontol 1985;56:63-73.

Okuda K, Tai H, Tanabe K, Suzuki H, Saito T, Kawase T, Saito Y, Wolff LF, Yoshie H. Platelet rich plasma combined with a porous hydroxyapatite graft for the treatment of intrabony periodontal defects in humans: A comparative controlled clinical study. J Periodontol 2005;76:890-898.

Kenney EB, Lekovic V, Han T, Carranza FA, Dimitrijevic B. The Use of a Porous Hydroxyapatite implant in periodontal defects I. Clinical results after six months. J Periodontol 1985;56:82-88.

Choukroun J, Dohan DM, Diss A, Dohan SL, Dohan AJJ, Mouhyi J, Gogly B. Platelet rich fibrin (PRF): a second generation platelet concentrate. Part lV: Clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:E56-60.

Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJJ, Mouhyi J, Gogly B. Platelet rich fibrin (PRF): A second generation platelet concentrate. Part ll: Platelet related biological features. Oral surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:E45-50.

Shirakata Y, Setoguchi T, Machigashira M, Matsuyama T, Furuichi Y, Hasegawa K, Yashimoto T, Izumi Y. Comparison of injectable calcium phosphate bone cement grafting and open flap debridement in periodontal intrabony defects. J Periodontol 2008;79:25-32.

Mora F, Ohuhayoun JP. Clinical evaluation of natural coral and porous hydroxyapatite implants in periodontal bone lesions: results of a 1 year follow up. J Clin Periodontol 1995;22:877-884.

Czuryszkiewicz-crana J, Banach J. Autogenous bone and PRP in the treatment of intrabony defects. Advances in Med Sci 2006;51:26-30.

Zohar R, Tenenbaum HC, Perio D. How predictable are periodontal regenerative procedures? JCDA 2005;71(9):675.

Addy M. The use of antiseptics in periodontal therapy. In: Lindhe J, Karring T, Lang NP. Clinical periodontology and implant dentistry. Blackwell Munkgard. 4th edition 2003;464-93.

Newman MG. Effect of 0.12% chlorhexidine on bacterial recolonization after periodontal surgery. J Periodontol 1989;60:577-89.

Reddy MS, Jeffcoat MK. Methods of assessing periodontal regeneration. Periodontol 2000. 1999;19:87-103.

Slotte C, Asklo B, Sultan J, Norderyd O. A Randomized Study of Open-Flap Surgery of 32 Intrabony Defects With and Without Adjunct Bovine Bone Mineral Treatment. J Periodontol 2012;83:999-1007.

Mazor Z, Horowitz RA, Del Corso M, Prasad HS, Rohre MD, Dohan Ehrenfest DM. Sinus floor augmentation with simultaneous implant placement using Choukroun’s PRF as sole grafting material : a radiographic and histologic study at 6 months. J Periodontol 2009;80:2056-64.

Yamamiya K, Okuda K, Kawase T, Hata K, Wolff LF, Yoshie H. Tissue engineered cultured periosteum used with PRP and hydroxyapatite in testing human osseous defects. J Periodontol 2008;79:811-818.

Dori F, Huszar T, Nikolidakis D, Tihanyi D, Horvath A, Arweiler NB, Gera I, Sculean A, Effect of platelet rich plasma on healing of intrabony defects treated with beta tricalcium phosphate and expanded polytetrafluroethylene membranes. J Periodontol 2008;79:660-669.